Zynex, an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, announced the appointment of Steven Dyson as Chief Executive Officer. His employment will begin on August 18, 2025.
Health Technology Insights: Mindful Lemon Partners with Qualifacts to Boost LA Care
Thomas Sandgaard, Founder of Zynex and Chairman of the Board since the company’s inception in 1996, will remain actively involved as Chairman and Chair of the Board’s Technology Committee.
Steven brings over 25 years of experience in the medical technology sector, primarily through his leadership at Apax, a global private equity firm. He has played a key role in acquiring, growing, and exiting numerous healthcare and medtech companies around the world. His board and transaction experience includes companies such as KCI (San Antonio, TX), Rodenstock (Germany), Healthium Medtech (India), Unilabs (Switzerland), and Neuraxpharm (Spain).
Health Technology Insights: Biogen Shares New Nusinersen Data to Advance SMA Outcomes
Steven will operate from the Zynex headquarters in Englewood, Colorado, while maintaining a residence in London, England. He holds a B.A. from Oxford University and a Ph.D. from Cambridge University.
“I am excited to step back from day-to-day operations and continue contributing as Chairman,” said Thomas Sandgaard. “Steven brings deep expertise and a proven track record in the medical sector. His leadership will be instrumental as we refocus our business strategy toward a more optimized payer mix and work to return Zynex to a strong growth trajectory.”
Newly appointed CEO Steven Dyson added, “I’m honored to join the Zynex team at this exciting time in the Company’s history and to have the opportunity to lead the Company back to a strong growth trajectory. Zynex’s strong foundation, built by Thomas over many years, provides an excellent platform to deliver exceptional value for all our stakeholders “
Health Technology Insights: Study: Virtual MSK Care Boosts Outcomes for Medicare Members
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
